HYFT technology

ImmunoPrecise Antibodies (IPA) announced a breakthrough in dengue vaccine development using its LENS^ai platform, powered by HYFT technology. The platform identified a conserved epitope across all dengue serotypes, paving the way for a universal vaccine. IPA plans to expand its AI-driven approach to other infectious diseases and oncology, streamlining vaccine development and potentially reducing costs. This discovery highlights AI’s potential to address complex challenges in biology.